1 Herranz MT Rivier G Khamashta MA Blaser KU Hughes GR . Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum1994; 37: 568–571.
2.
2 Toubi E Khamashta MA Panarra A Hughes GR . Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med1995; 99: 397–401.
3.
3 Cimaz R Meroni PL Shoenfield Y . Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Lupus2006; 15: 191–197.
4.
4 Mikdashi J Krumholz A Handwerger B . Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology2005; 64: 2102–2107.
5.
5 Appenzeller S Cendes F Costallat LT . Epileptic seizures in systemic lupus erythematosus. Neurology2004; 63: 1808–1812.
6.
6 Ranua J Luoma K Peltola J . Anticardiolipin and antinuclear antibodies in epilepsy–a population-based cross-sectional study. Epilepsy Res2004; 58: 13–18.
7.
7 Ganor Y Goldberg-Stern H Lerman-Sagie T Teichberg V Levite M . Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA. Epilepsy Res2005; 65: 11–22.
8.
8 Ranua J Luoma K Auvinen A . Antimitochondrial antibodies in patients with epilepsy. Epilepsy Behav2005; 7: 95–97.
9.
9 Hinchey J Chaves C Appignani B . A reversible posterior leukoencephalopathy syndrome. N Engl J Med1996; 334: 494–500.
10.
10 Punaro M Abou-Jaoude P Cimaz R Ranchin B . Unusual neurologic manifestations (2). Posterior reversible encephalopathy syndrome (PRES) in the context of juvenile SLE. Lupus2007; 16: 576–579.
11.
11 Leroux G Sellam J Costedoat-Chalumeau N . Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus2008; 17: 139–147.
12.
12 Hom G Graham RR Modrek B . Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med2008; 358: 900–909.
13.
13 Bautista JF Kelly JA Harley JB Gray-McGuire C . Addressing genetic heterogeneity in complex disease: finding seizure gens in systemic lupus erythematosus. Epilepsia2008; 49: 527–530.
14.
14 Koppel BS . Connective tissue diseases. In: JJR Engel TA Pedley , (eds), Epilepsy a comprehensive textbook.Lippincott Williams & Wilkins, Philadelphia, PA, USA; 2008. p. 2653–2660.
15.
15 Rood MJ Ten Cate R van Suijlekom-Smit LWA . Childhood-onset systemic lupus erythematosus. Scand J Rheumatol1999; 28: 222–226.
16.
16 Ward MM Pyun E Studenski S . Causes of death in systemic lupus erythematosus. Arthritis Rheum1995; 38: 1492–1499.
17.
17 Futrell N Schultz LR Millikan C . Central nervous system disease in patients with systemic lupus erythematosus. Neurology1992; 42: 1649–1657.
18.
18 West SG Emlen W Wener MH Kotzin BL . Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med1995; 99: 153–163.
19.
19 West SG . Neuropsychiatric lupus. Rheum Dis Clin North Am1994; 20: 129–158.
20.
20 Martinez X Tintore M Montalban J Ordi J Vilardell M Codina A . Antibodies against gangliosides in patients with SLE and neurological manifestations. Lupus1992; 1: 299–302.
21.
21 Pereira RM Yoshinari NH DeOliveira RM Cossermelli W . Antiganglioside antibodies in patients with neuropsychiatric systemic lupus erythematosus. Lupus1992; 1: 175–179.
22.
22 Liou HH Wang CR Chou HC . Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons. Life Sci1994; 54: 1119–1125.
